Friday 28 June 2019
Symposium Genitourinary Cancer and Quality of Life
Panorama Room - 15th floor, Inntel Hotels Rotterdam Centre
Rotterdam, The Netherlands


This symposium will focus on interventions in improving cancer care, quality of life and psychological wellbeing in survivors of genitourinary cancers.

The symposium will address:

  • What is quality of life and how to measure it

  • The effects of treatment for testicular cancer on quality of life

  • The use of novel radiotherapy techniques to improve quality of life

  • The effects of radiotherapy for genitourinary tumors on sexual functioning

  • The effects of hormonal manipulation and chemotherapy for genitourinary tumors on quality of life

  • Program

    Now Available!
    Click here.

  • CME

    CME will be available for Dutch attendees
    NVRO (Nederlandse Vereniging voor Radiotherapie en Oncologie):
    6 CME Credits

    NIV (Nederlandse Internisten Vereniging):
    6 CME credits

    NVU (Nederlandse Vereniging voor Urologie):
    6 CME credits

  • Chair

    Prof. Luca Incrocci, MD, PhD
    Erasmus MC
    Rotterdam, The Netherlands

  • Register

    Click here to register online
    Registration costs: EUR 50
    Registration is open till 19 June 2019

Target Group

Health care providers dealing with patients with genito-urinary cancers, including (but not limited to) radiation oncologists, medical oncologists, urologists, radiation therapy technologists, and oncology nurses.



Astellas Pharma BV

AstraZeneca BV

Elekta BV

Janssen-Cilag BV



For more information about your registration, please contact Status Plus, via, or via phone +31 (0)75-647 6370